NeuTrace EP Mapping System v.2.1

FDA 510(k) K233160 · Anumana, Inc.

Substantially Equivalent

510(k) numberK233160

Submission

Device name
NeuTrace EP Mapping System v.2.1
Applicant
Anumana, Inc.
Cambridge, MA, US
Received
September 27, 2023
Decision date
November 25, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DQK – Computer, Diagnostic, Programmable
Device class
Class II (moderate risk)
Regulation
21 CFR 870.1425
Specialty
Cardiovascular

Other 510(k)s with product code DQK

510(k)DeviceApplicantDecision
K262005Affera Integrated Mapping SystemDQK · Special Medtronic, Inc.08/21/2026SE
K253692AVVIGO™+ Multi-Modality Guidance SystemDQK · Traditional Boston Scientific08/21/2026SE
K253576CorVista System® with PCWP Add-OnDQK · Traditional Analytics For Life, Inc.07/26/2026SE
K262006EnSite™ X EP SystemDQK · Special Abbott Medical07/15/2026SE
K252978ScioCardio ECG Analysis PlatformDQK · Traditional Synergen Technology Labs, LLC07/09/2026SE
K253463ILR ECG Analyzer (IM007)DQK · Traditional Implicity, Inc.07/02/2026SE
K261119NorthStar Mapping System (MAP01 or MAP01-01)DQK · Special Imricor Medical Systems, Inc.06/30/2026SE
K253088OneStim-DUO Cardiac Stimulator (MP5003-4CO)DQK · Traditional Micropace Pty, Ltd.06/12/2026SE
K261329Intra-Operative Positioning System (IOPS) (MC-1);IOPS Viewpoint Simple Curve Catheter…DQK · Special Centerline Biomedical06/10/2026SE
K252859ZEUS Platform (FG0501US)DQK · Traditional iRhythm Technologies, Inc.05/29/2026SE

More from iRhythm Technologies, Inc.

510(k)DeviceDecision
K260300WatchMate SoftwareQIH · Traditional 06/15/2026SE
K253801ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)SHP · Traditional 04/07/2026SE
K252360ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)SAT · Traditional 03/28/2026SE
K250652ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)QYE · Traditional 07/28/2025SE
K232699Low Ejection Fraction AI-ECG AlgorithmQYE · Traditional 09/28/2023SE

Questions and answers

When was NeuTrace EP Mapping System v.2.1 cleared by the FDA?

NeuTrace EP Mapping System v.2.1 (K233160) received a 510(k) decision of Substantially Equivalent on November 25, 2023, 59 days after the submission was received.

What is the product code of K233160?

The FDA product code is DQK – Computer, Diagnostic, Programmable, a Class II (moderate risk) device regulated under 21 CFR 870.1425.